Table 6.
Bleeding complications of percutaneous native kidney biopsies in all facilities of nephrology and pediatric nephrology
| Year | 2015 | 2016 | 2017 | Total |
|---|---|---|---|---|
| Number of facilities | 147 | 146 | 154 | 447 |
| Number of biopsies | 5548 | 5691 | 6103 | 17,342 |
| Macroscopic hematuria with no treatment (%) | 160 (2.9) | 178 (3.1) | 198 (3.3) | 536 (3.1) |
| Bleeding complications with treatment (%) | 60 (1.1) | 54 (1.0) | 64 (1.0) | 178 (1.0) |
| Erythrocyte transfusiona (%) | 38 (0.7) | 39 (0.7) | 44 (0.7) | 121 (0.7) |
| Surgical hemostasisa (%) | 1 (0.02) | 0 (0) | 0 (0.0) | 1 (0.006) |
| Transcatheter arterial embolizationa (%) | 14 (0.3) | 8 (0.1) | 10 (0.2) | 32 (0.2) |
| Bladder lavagea (%) | 23 (0.4) | 17 (0.3) | 25 (0.4) | 65 (0.4) |
| Nephrectomya (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Death from severe bleedinga (%) | 0 (0) | 0 (0) | 1 (0.02) | 1 (0.006) |
aMultiple selections allowed in the same biopsy